Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 224

    1.

    Transient trimethylaminuria related to menstruation.

    Shimizu M, Cashman JR, Yamazaki H.

    BMC Med Genet. 2007 Jan 27;8:2.PMID: 17257434 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.

    Yamazaki H, Fujita H, Gunji T, Zhang J, Kamataki T, Cashman JR, Shimizu M.

    Mol Genet Metab. 2007 Jan;90(1):58-63. Epub 2006 Sep 25.PMID: 16996766 [PubMed - indexed for MEDLINE]Related articles

    4.

    Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria.

    Cashman JR, Camp K, Fakharzadeh SS, Fennessey PV, Hines RN, Mamer OA, Mitchell SC, Nguyen GP, Schlenk D, Smith RL, Tjoa SS, Williams DE, Yannicelli S.

    Curr Drug Metab. 2003 Apr;4(2):151-70. Review.PMID: 12678693 [PubMed - indexed for MEDLINE]Related articles

    5.

    Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.

    Cashman JR, Bi YA, Lin J, Youil R, Knight M, Forrest S, Treacy E.

    Chem Res Toxicol. 1997 Aug;10(8):837-41.PMID: 9282831 [PubMed - indexed for MEDLINE]Related articles

    6.

    Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children.

    Chalmers RA, Bain MD, Michelakakis H, Zschocke J, Iles RA.

    J Inherit Metab Dis. 2006 Feb;29(1):162-72.PMID: 16601883 [PubMed - indexed for MEDLINE]Related articles

    7.

    Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.

    Yeung CK, Adman ET, Rettie AE.

    Arch Biochem Biophys. 2007 Aug 15;464(2):251-9. Epub 2007 May 2.PMID: 17531949 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.

    Shimizu M, Yano H, Nagashima S, Murayama N, Zhang J, Cashman JR, Yamazaki H.

    Drug Metab Dispos. 2007 Mar;35(3):328-30. Epub 2006 Dec 1.PMID: 17142560 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FM03) gene in patients with fish-odour syndrome.

    Dolphin CT, Janmohamed A, Smith RL, Shephard EA, Phillips IR.

    Pharmacogenetics. 2000 Dec;10(9):799-807.PMID: 11191884 [PubMed - indexed for MEDLINE]Related articles

    11.

    A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria.

    Forrest SM, Knight M, Akerman BR, Cashman JR, Treacy EP.

    Pharmacogenetics. 2001 Mar;11(2):169-74.PMID: 11266081 [PubMed - indexed for MEDLINE]Related articles

    12.

    Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria.

    Zhang J, Tran Q, Lattard V, Cashman JR.

    Pharmacogenetics. 2003 Aug;13(8):495-500.PMID: 12893987 [PubMed - indexed for MEDLINE]Related articles

    13.

    Trimethylaminuria and a human FMO3 mutation database.

    Hernandez D, Addou S, Lee D, Orengo C, Shephard EA, Phillips IR.

    Hum Mutat. 2003 Sep;22(3):209-13. Review.PMID: 12938085 [PubMed - indexed for MEDLINE]Related articles

    14.

    Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.

    Motika MS, Zhang J, Zheng X, Riedler K, Cashman JR.

    Mol Genet Metab. 2009 Jun;97(2):128-35. Epub 2009 Feb 27.PMID: 19321370 [PubMed - indexed for MEDLINE]Related articles

    15.

    Population-specific polymorphisms of the human FMO3 gene: significance for detoxication.

    Cashman JR, Akerman BR, Forrest SM, Treacy EP.

    Drug Metab Dispos. 2000 Feb;28(2):169-73.PMID: 10640514 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Mild trimethylaminuria caused by common variants in FMO3 gene.

    Zschocke J, Kohlmueller D, Quak E, Meissner T, Hoffmann GF, Mayatepek E.

    Lancet. 1999 Sep 4;354(9181):834-5.PMID: 10485731 [PubMed - indexed for MEDLINE]Related articles

    17.

    A spectrum of molecular variation in a cohort of Italian families with trimethylaminuria: identification of three novel mutations of the FM03 gene.

    Teresa E, Lonardo F, Fiumara A, Lombardi C, Russo P, Zuppi C, Scarano G, Musumeci S, Gianfrancesco F.

    Mol Genet Metab. 2006 Jun;88(2):192-5. Epub 2006 Apr 4.PMID: 16600650 [PubMed - indexed for MEDLINE]Related articles

    18.

    Trimethylaminuria (fish-odor syndrome): a case report.

    Arseculeratne G, Wong AK, Goudie DR, Ferguson J.

    Arch Dermatol. 2007 Jan;143(1):81-4.PMID: 17224546 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort.

    Akerman BR, Lemass H, Chow LM, Lambert DM, Greenberg C, Bibeau C, Mamer OA, Treacy EP.

    Mol Genet Metab. 1999 Sep;68(1):24-31.PMID: 10479479 [PubMed - indexed for MEDLINE]Related articles

    20.

    Structural organization of the human flavin-containing monooxygenase 3 gene (FMO3), the favored candidate for fish-odor syndrome, determined directly from genomic DNA.

    Dolphin CT, Riley JH, Smith RL, Shephard EA, Phillips IR.

    Genomics. 1997 Dec 1;46(2):260-7.PMID: 9417913 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data